Innovation
Neuralink Receives FDA Approval for Non-Invasive Brain Interface
Neuralink has secured FDA clearance for a revolutionary non-invasive neural interface device, bringing brain-computer communication technology to the consumer market for the first time.
AI Editorial Insight
Non-invasive BCI is the first viable path to mainstream neural computing.
Neuralink has achieved a major regulatory milestone with FDA approval of its non-invasive brain-computer interface, a headband-style device that can read neural signals to enable direct thought-to-text communication.
In clinical trials, participants achieved typing speeds of 40 words per minute using thought alone. The technology has immediate applications for individuals with paralysis and ALS.
Advertisement
Privacy advocates have raised concerns about the collection of neural data, calling for regulatory frameworks specifically addressing brain data protection.
Original Source
TechCrunch